Hepatitis C in Patients with Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes

• Published in: Clinical infectious diseases Vol. 66; no. 11; pp. 1742 - 1750
• Main Authors: Younossi, Zobair M, Stepanova, Maria, Asselah, Tarik, Foster, Graham, Patel, Keyur, Brau, Norbert, Swain, Mark, Tran, Tram, Esteban, Rafael, Colombo, Massimo, Pianko, Stephen, Henry, Linda, Bourliere, Marc
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 17.05.2018
• Subjects: Clinical outcomes; Clinical trials; Fibrosis; Hepatitis; Hepatitis C; Interferon; Liver; Liver diseases; Medical research; Patients; Ribavirin; Viruses; fatigue; healthy liver; work productivity; vitality; direct-acting antivirals

While the necessity of treatment of HCV patients with advanced liver disease is widely accepted, the benefit of treating HCV patients without significant liver disease is less well established. Our aim was to assess the effect of treating HCV in patients with no or minimal fibrosis (F0-F1) on patien...